Jeisys Medical Inc
KOSDAQ:287410
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
KR |
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
970.7B KRW | 36.3 | |
US |
Shockwave Medical Inc
NASDAQ:SWAV
|
215.1B USD | 1 315 | ||
US |
Abbott Laboratories
NYSE:ABT
|
187B USD | 33.2 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
148.4B USD | 74.7 | ||
US |
Stryker Corp
NYSE:SYK
|
132.6B USD | 39.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
113.8B USD | 64.4 | ||
IE |
Medtronic PLC
NYSE:MDT
|
109B USD | 29.7 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
69.6B USD | 52.8 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
61.3B EUR | 33.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.8B USD | 36.7 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
364.6B CNY | 30 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.